Načítá se...
EXTH-68. RECURRENT XENOGRAFT TUMORS UPREGULATE EGFR AFTER LENTIVIRAL VECTOR MEDIATED SUICIDE GENE THERAPY FOR GLIOBLASTOMA, BUT ARE RESISTANT TO COMBINATORIAL TREATMENT WITH ERLOTINIB
BACKGROUND: Lentiviral vector mediated herpes simplex virus thymidine kinase (HSV-Tk)/ ganciclovir (GCV) therapy is a very promising therapeutic option for the treatment of glioblastoma (GBM). Although this therapy leads to complete remission of GBM in an orthotopic PDX model, recurrent tumors are o...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692650/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.360 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|